Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial
Authors:
- Kenneth W. MahaffeyKMKenneth W. Mahaffey
- June L. WampoleJWJune L. Wampole
- Amanda StebbinsASAmanda Stebbins
- Lisa G. BerdanLBLisa G. Berdan
- Donna McAfeeDMDonna McAfee
- Tyrus L. RorickTRTyrus L. Rorick
- John K. FrenchJFJohn K. French
- Neal S. KleimanNKNeal S. Kleiman
- Christopher M. O'COnnorCOChristopher M. O'COnnor
- Eric A. CohenECEric A. Cohen
- Christopher B. GrangerCGChristopher B. Granger
- Paul W. ArmstrongPAPaul W. Armstrong
- 1 March 2011
- journal article
- research article
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 32 (2) , 178-187
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary InterventionJAMA, 2007
- Comparing classifications of death in the Mode Selection Trial: Agreement and disagreement among site investigators and a clinical events committeeContemporary Clinical Trials, 2006
- Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary interventionAmerican Heart Journal, 2005
- Misreporting of myocardial infarction end points: Results of adjudication by a central clinical events committee in the PARAGON-B trialAmerican Heart Journal, 2002
- Systematic adjudication of myocardial infarction end-points in an international clinical trialTrials, 2001
- Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trialThe Lancet, 2000
- Grading Diabetic Retinopathy from Stereoscopic Color Fundus Photographs—An Extension of the Modified Airlie House ClassificationOphthalmology, 1991
- The FDA's Critique of the Anturane Reinfarction TrialNew England Journal of Medicine, 1980
- Sulfinpyrazone in the Prevention of Sudden Death after Myocardial InfarctionNew England Journal of Medicine, 1980